|
San Diego, CA - November 23, 2004
LA
JOLLA PHARMACEUTICAL COMPANY PROVIDES UPDATE ON RIQUENT PROGRAM
San Diego, CA - November 4, 2004
LA JOLLA PHARMACEUTICAL COMPANY
REPORTS THIRD QUARTER 2004 FINANCIAL RESULTS
San Diego, CA - October 29, 2004
LA JOLLA PHARMACEUTICAL COMPANY
PRESENTS AT AMERICAN COLLEGE OF RHEUMATOLOGY AND AMERICAN SOCIETY
OF NEPHROLOGY ANNUAL MEETINGS
San Diego, CA - October 14, 2004
LA JOLLA PHARMACEUTICAL COMPANY RECEIVES LETTER FROM FDA ABOUT RIQUENT
San Diego, CA - October 12, 2004
LA JOLLA PHARMACEUTICAL COMPANY
APPOINTS
CRAIG SMITH M.D. TO ITS BOARD OF DIRECTORS
San Diego, CA - September 22, 2004
LA JOLLA PHARMACEUTICAL TO
PRESENT AT UBS GLOBAL LIFE SCIENCES CONFERENCE
San Diego, CA - August 5, 2004
LA JOLLA PHARMACEUTICAL COMPANY
REPORTS SECOND QUARTER 2004 FINANCIAL RESULTS
San Diego, CA - August 2, 2004
LA JOLLA PHARMACEUTICAL
REACHES AGREEMENT WITH CARDIO-RENAL DIVISION OF FDA REGARDING
PHASE 4 TRIAL DESIGN UNDER SPECIAL PROTOCOL ASSESSMENT
San Diego, CA - June 24, 2004
LA JOLLA PHARMACEUTICAL ANNOUNCES
PUBLICATION OF REVIEW ARTICLES REGARDING ITS TWO DRUG CANDIDATES
San Diego, CA - June 10, 2004
LA JOLLA PHARMACEUTICAL
PRESENTS AT EUROPEAN RHEUMATOLOGY MEDICAL CONFERENCE
San Diego, CA - June 9, 2004
LA JOLLA PHARMACEUTICAL TO
PRESENT AT NEEDHAM BIOTECHNOLOGY CONFERENCE
San Diego, CA - June 2, 2004
LA JOLLA PHARMACEUTICAL TO
PRESENT AT PACIFIC GROWTH EQUITIES LIFE SCIENCES CONFERENCE
San Diego, CA - May 13, 2004
LA JOLLA PHARMACEUTICAL AUTOIMMUNE
THROMBOSIS DISEASE TARGET HIGHLIGHTED IN TWO PEER-REVIEWED JOURNALS
San Diego, CA - May 10, 2004
LA JOLLA PHARMACEUTICAL DATA
ON RIQUENT® PRESENTED AT LUPUS MEDICAL CONFERENCE
San Diego, CA - May 6, 2004
LA JOLLA PHARMACEUTICAL
COMPANY
REPORTS FIRST QUARTER 2004 FINANCIAL RESULTS
San Diego, CA - April 21, 2004
LA JOLLA PHARMACEUTICAL TO
PRESENT AT 7TH INTERNATIONAL CONGRESS ON SYSTEMIC LUPUS ERYTHEMATOSUS
AND RELATED CONDITIONS
San Diego, CA - March 22, 2004
LA JOLLA PHARMACEUTICAL TO
PRESENT AT
WELLS FARGO SECURITIES HEALTHCARE CONFERENCE
San Diego, CA - March 11, 2004
LA JOLLA PHARMACEUTICAL TO
PRESENT ADDITIONAL RIQUENT® RESULTS AT SG COWEN HEALTHCARE
CONFERENCE
San Diego, CA - March 10, 2004
LA JOLLA PHARMACEUTICAL ANNOUNCES EXECUTIVE PROMOTION
San Diego, CA - March 9, 2004
LA JOLLA PHARMACEUTICAL
TO PRESENT AT SG COWEN HEALTHCARE CONFERENCE
San Diego, CA - March 5, 2004
LA JOLLA PHARMACEUTICAL COMPANY
ANNOUNCES EXERCISE OF OVER-ALLOTMENT OPTION
San Diego, CA - March 3, 2004
LA JOLLA PHARMACEUTICAL TO
PRESENT AT LEHMAN HEALTHCARE CONFERENCE
San Diego, CA - March 2, 2004
LA JOLLA PHARMACEUTICAL COMPANY
REPORTS FOURTH QUARTER AND YEAR END 2003 FINANCIAL RESULTS
San Diego, CA - February 26, 2004
LA JOLLA PHARMACEUTICAL
COMPANY COMPLETES STOCK OFFERING
San Diego, CA - February 20, 2004
LA JOLLA PHARMACEUTICAL COMPANY
ANNOUNCES COMMON STOCK OFFERING
San Diego, CA - February 17, 2004
LA
JOLLA PHARMACEUTICAL’S NEW DRUG APPLICATION FOR LUPUS DRUG
CANDIDATE RIQUENT® ACCEPTED FOR REVIEW BY FDA
|